knowledge -WSS

knowledge

author：leisure time 2025-09-29 11:55:03 Page View：5832

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Prior authorization reform is both possible and imperative
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

Maisha Meds is a PBM, but don't call it that

ZachariahKirimiisapharmacistwhousestheMaishaMedsapptohelpmanagehisinventoryandoffersubsidizedproduct

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

CourtesySanofiLONDON—Inabidtoexpanditspipelineofinflammation-targetingdrugs,SanofisaidTuesdayitwasac

knowledge

Wikipedia

leisure time

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal